Back to KROS

ADAR1 Capital Management, LLC → KROS

ADAR1 Capital Management, LLC KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
5
Latest value
$2.7M
Q3 2026
Peak value
$2.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$384K
Q4 2025$384K
Q1 2026$1.1M
Q2 2026$2.6M
Q3 2026$2.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$2.7M239.2K——
Q2 2026$2.6M246.8K——
Q1 2026$1.1M97.3K——
Q4 2025$384K18.9K——
Q4 2025$384K18.9K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other ADAR1 Capital Management, LLC positions

AAVXF

ABIVAX SA

$240.5M
AAVXF

ABIVAX SA

$203.1M
AAVXF

ABIVAX SA

$177.6M
AAVXF

ABIVAX SA

$177.6M
AAVXF

ABIVAX SA

$155.2M
SPY

STATE STR SPDR S&P 500 ETF T

$135.5M
PB

PROTAGONIST THERAPEUTICS INC

$134M
PB

PROTAGONIST THERAPEUTICS INC

$117.8M